p21+TREM2+ senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease

Cellular senescence drives chronic sterile inflammation during aging via the senescence-associated secretory phenotype, yet the senescent cell types responsible are poorly defined. Macrophages share multiple features of senescence, including inflammatory secretion, yet whether macrophages can adopt a senescent state remains unclear. Here we identify p21⁺Trem2⁺ senescent macrophages as a major source of inflammaging, using primary mouse and human macrophage models of DNA damage and cholesterol-induced senescence characterized by multi-omic profiling. We found that senescent macrophages exhibit a distinctive p21-TREM2 expression profile and senescence-associated secretory phenotype, driven in part by type I interferon signaling via cytosolic mitochondrial DNA. We also found that senescent macrophage accumulation occurs in aging, metabolic dysfunction-associated steatotic liver disease mouse livers, and is enriched in human cirrhotic liver tissue. Finally, senolytic treatment targeting senescent macrophages reduced liver inflammation and steatosis in both aged mice and mice with metabolic dysfunction-associated steatotic liver disease. These findings establish macrophage senescence as a central driver of chronic inflammation in aging and metabolic liver disease, and a tractable therapeutic target.

Authors

Institutions

Publication Details

Journal
Nature Aging
Published
2026-04-16
DOI
https://doi.org/10.1038/s43587-026-01101-6
Citations
1
Primary Topic
Telomeres, Telomerase, and Senescence
Type
article
Field-Weighted Citation Impact
19.92

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

p21+TREM2+ senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease

Jacob Rose, Abhijit Kale, Birgit Schilling, Indra Heckenbach et al.
1 citations
Nature Aging
Telomeres, Telomerase, and Senescence
19.92
article

p21+TREM2+ senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease

Jacob Rose, Abhijit Kale, Birgit Schilling, Indra Heckenbach, Yuming Jiang, Grasiela Torres, Mark Larsen, Lia Farahi, Aldons Jake Lusis, Eric Verdin, Alexander J. Napior, Itzetl Avila, Cyril Lagger, Anthony J. Covarrubias, João Pedro de Magalhães, Julia J. Mack, Isaiah Little, Steven J. Bensinger, Jesse G. Meyer, Chantle Edillor, Morten Scheibye‐Knudsen, M Krieger, Julia Gensheimer, Charles Brenner, Kushan Chowdhury, Mridul Sharma, K. Williams, Ram Singh, Edwin D.J. Lopez Gonzalez, Anika Dhingra, Lizeth Estrada, Carla M. Koehler, Ronak Hegde, Andreea C. Alexandru, Simon Hui, Cristian Ponce, Christina Y. Deng, Jose A. Soto, Ivan A. Salladay-Perez
article en
1 citations

Abstract

Cellular senescence drives chronic sterile inflammation during aging via the senescence-associated secretory phenotype, yet the senescent cell types responsible are poorly defined. Macrophages share multiple features of senescence, including inflammatory secretion, yet whether macrophages can adopt a senescent state remains unclear. Here we identify p21⁺Trem2⁺ senescent macrophages as a major source of inflammaging, using primary mouse and human macrophage models of DNA damage and cholesterol-induced senescence characterized by multi-omic profiling. We found that senescent macrophages exhibit a distinctive p21-TREM2 expression profile and senescence-associated secretory phenotype, driven in part by type I interferon signaling via cytosolic mitochondrial DNA. We also found that senescent macrophage accumulation occurs in aging, metabolic dysfunction-associated steatotic liver disease mouse livers, and is enriched in human cirrhotic liver tissue. Finally, senolytic treatment targeting senescent macrophages reduced liver inflammation and steatosis in both aged mice and mice with metabolic dysfunction-associated steatotic liver disease. These findings establish macrophage senescence as a central driver of chronic inflammation in aging and metabolic liver disease, and a tractable therapeutic target.

Nature AgingVol. 6(4)
Kyiv School of Economics (UA), University of Copenhagen (DK), Cedars-Sinai Medical Center (US), Buck Institute for Research on Aging (US), University of California, Los Angeles (US), UCLA Health (US), Department of Health and Aged Care (AU), City of Hope (US), Comprehensive Cardiovascular (US), Broad Center (US), UCLA Jonsson Comprehensive Cancer Center
American Federation for Aging Research, American Heart Association, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources
Openalex Percentile: Top 1%
Telomeres, Telomerase, and Senescence
19.92
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.